enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW)

CUSIP: 29286M113

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / *W EXP 10/31/202
Total 13F shares
4,762,265
Share change
-473,569
Total reported value
$4,024,339
Price per share
$0.84
Number of holders
15
Value change
-$399,359
Number of buys
1
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 29286M113?
CUSIP 29286M113 identifies ENGNW - enGene Therapeutics Inc. - *W EXP 10/31/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ENGNW - enGene Therapeutics Inc. - *W EXP 10/31/202 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FCPM III SERVICES B.V.
13F
Company
mixed-class rows
11,556,099
mixed-class rows
$63,318,587 30 Sep 2024
13F
Forbion Growth Opportunities Fund I Cooperatief U.A.
3/4/5
10%+ Owner
class O/S missing
6,798,362
$60,505,422 30 Oct 2024
Fonds de solidarite des travailleurs et des travailleuses du Quebec
3/4/5 13D/G
10%+ Owner
4.5%
from 13D/G
3,036,153
$45,542,295 18 Apr 2024
Lumira Capital Investment Management Inc.
3/4/5
10%+ Owner
class O/S missing
3,849,299
$38,492,990 20 Feb 2024
VR Adviser, LLC
13F
Company
5.3%
3,565,841
$23,534,551 30 Sep 2024
13F
Blue Owl Capital Holdings LP
13F
Company
mixed-class rows
3,570,146
mixed-class rows
$20,917,622 30 Sep 2024
13F
Deep Track Capital, LP
13F
Company
3.9%
2,607,633
$17,210,378 30 Sep 2024
13F
BVF INC/IL
13F
Company
mixed-class rows
3,196,439
mixed-class rows
$15,660,530 30 Sep 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.5%
2,329,768
$15,376,469 30 Sep 2024
13F
Kynam Capital Management, LP
13F
Company
2.6%
1,736,227
$11,459,098 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
1.8%
1,189,952
$9,186,429 30 Sep 2024
13F
Omega Fund Management, LLC
13F
Company
mixed-class rows
1,397,859
mixed-class rows
$7,779,110 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.5%
1,000,000
$6,625,000 30 Sep 2024
13F
Cormorant Asset Management, LP
13F
Company
1.5%
1,000,000
$6,600,000 30 Sep 2024
13F
Adage Capital Management, L.P.
13D/G
3%
1,528,768
$6,115,072 $0 31 Dec 2024
Logos Global Management LP
13F
Company
1.2%
800,000
$5,280,000 30 Sep 2024
13F
Soleus Capital Management, L.P.
13F
Company
1.2%
800,000
$5,280,000 30 Sep 2024
13F
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
1.1%
747,750
$4,935,150 30 Sep 2024
13F
Boxer Capital, LLC
13F
Company
1.1%
727,900
$4,804,140 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
1%
681,545
$4,498,196 30 Sep 2024
13F
Vivo Capital, LLC
13F
Company
1%
678,705
$4,479,453 30 Sep 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.99%
663,000
$4,375,800 30 Sep 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.46%
306,034
$2,019,824 30 Sep 2024
13F
Ghost Tree Capital, LLC
13F
Company
0.24%
160,898
$1,061,927 30 Sep 2024
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.14%
94,219
$621,845 30 Sep 2024
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
192,334
$274,076 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.06%
39,621
$261,499 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.05%
34,416
$227,146 30 Sep 2024
13F
Calamos Advisors LLC
13F
Company
class O/S missing
150,000
$213,758 30 Sep 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
104,622
$209,244 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
27,516
$181,605 30 Sep 2024
13F
TENOR CAPITAL MANAGEMENT Co., L.P.
13F
Company
class O/S missing
55,243
$116,010 30 Sep 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.02%
13,262
$87,529 30 Sep 2024
13F
WHITEBOX ADVISORS LLC
13F
Company
class O/S missing
33,333
$69,999 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.01%
8,193
$54,074 30 Sep 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
7,915
$52,000 30 Sep 2024
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
0.01%
5,574
$36,788 30 Sep 2024
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
class O/S missing
23,570
$33,588 30 Sep 2024
13F
CSS LLC/IL
13F
Company
class O/S missing
16,895
$32,945 30 Sep 2024
13F
ADAR1 Capital Management, LLC
13F
Company
0%
1,970
$13,002 30 Sep 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,138
$7,511 30 Sep 2024
13F
UBS Group AG
13F
Company
class O/S missing
3,208
$2,759 30 Sep 2024
13F
CLEAR STREET LLC
13F
Company
class O/S missing
200
$420 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
200
$172 30 Sep 2024
13F
Forbion Growth Sponsor FEAC I B.V.
3/4/5
10%+ Owner
mixed-class rows
5,502,338
mixed-class rows
31 Oct 2023
Forbion Capital Fund III Cooperatief U.A.
3/4/5
10%+ Owner
class O/S missing
2,894,735
31 Oct 2023
Jason David Hanson
3/4/5
Chief Executive Officer, Director
class O/S missing
512,826
31 Oct 2023
Richard P. Bryce
3/4/5
Chief Medical Officer
class O/S missing
153,000
30 Nov 2023
James C. Sullivan
3/4/5
Chief Scientific Officer
class O/S missing
118,509
31 Oct 2023
BVF PARTNERS L P/IL
3/4/5
10%+ Owner
class O/S missing
104,257
31 Oct 2023

Institutional Holders of enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW) as of Q4 2024

As of 31 Dec 2024, enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,762,265 shares. The largest 10 holders included FCPM III SERVICES B.V., BVF INC/IL, Omega Fund Management, LLC, Saba Capital Management, L.P., Calamos Advisors LLC, D. E. Shaw & Co., Inc., TENOR CAPITAL MANAGEMENT Co., L.P., Blue Owl Capital Holdings LP, WHITEBOX ADVISORS LLC, and STATE OF WISCONSIN INVESTMENT BOARD. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
14
Q4 2024 holders
15
Holder diff
1
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.